Renal function is associated with one-month and one-year mortality in patients with intracerebral hemorrhage
- PMID: 36701340
- PMCID: PMC9879419
- DOI: 10.1371/journal.pone.0269096
Renal function is associated with one-month and one-year mortality in patients with intracerebral hemorrhage
Abstract
Objective: This study evaluated short-term (1-month) and long-term (1-year) mortality risks associated with the glomerular filtration rate (eGFR) on admission for patients with intracerebral hemorrhage.
Methods: From the Taiwan Stroke Registry data from April 2006 to December 2016, we identified and stratified patients with intracerebral hemorrhage into five subgroups by the eGFR level on admission: ≥90, 60-89, 30-59, 15-29, and <15 mL/min/1.73 m2 or on dialysis. Risks for 1-month and 1-year mortality after intracerebral hemorrhage were compared by the eGFR levels.
Results: Both the 1-month and 1-year mortality rates progressively increased with the decrease in eGFR levels. The 1-month mortality rate in patients with eGFR < 15 mL/min/1.73 m2 or on dialysis was approximately 5.5-fold greater than that in patients with eGFR ≥ 90 mL/min/1.73 m2 (8.31 versus 1.50 per 1000 person-days), with an adjusted hazard ratio (HR) of 4.59 [95% confidence interval (CI) = 2.71-7.78]. Similarly, the 1-year mortality in patients with eGFR < 15 mL/min/1.73 m2 or on dialysis was 7.5 times that in patients with eGFR ≥ 90 mL/min/1.73 m2 (2.34 versus 0.31 per 1000 person-days), with an adjusted HR of 4.54 (95% CI 2.95-6.98).
Conclusion: Impairment of renal function is an independent risk factor for mortality in patients with intracerebral hemorrhage in a gradual way. The eGFR level is a prognostic indicator for patients with intracerebral hemorrhage.
Copyright: © 2023 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Renal function is associated with 1-month and 1-year mortality in patients with ischemic stroke.Atherosclerosis. 2018 Feb;269:288-293. doi: 10.1016/j.atherosclerosis.2017.11.029. Epub 2017 Dec 11. Atherosclerosis. 2018. PMID: 29254692
-
Renal dysfunction increases the risk of recurrent stroke in patients with acute ischemic stroke.Atherosclerosis. 2018 Oct;277:15-20. doi: 10.1016/j.atherosclerosis.2018.07.033. Epub 2018 Jul 27. Atherosclerosis. 2018. PMID: 30170219
-
Effects of estimated glomerular filtration rate on clinical outcomes in patients with intracerebral hemorrhage.BMC Neurol. 2022 Jan 10;22(1):19. doi: 10.1186/s12883-022-02551-2. BMC Neurol. 2022. PMID: 35012476 Free PMC article.
-
Intravenous tissue plasminogen activator for acute ischemic stroke in patients with renal dysfunction.QJM. 2022 Jan 9;114(12):848-856. doi: 10.1093/qjmed/hcaa237. QJM. 2022. PMID: 32770252
-
Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission.Stroke. 2018 Dec;49(12):2896-2903. doi: 10.1161/STROKEAHA.118.022011. Stroke. 2018. PMID: 30571413 Free PMC article.
Cited by
-
Epidemiology and Risk Factors for Stroke in Chronic Kidney Disease: A Narrative Review.Biomedicines. 2023 Aug 27;11(9):2398. doi: 10.3390/biomedicines11092398. Biomedicines. 2023. PMID: 37760839 Free PMC article. Review.
-
Intracerebral Hemorrhage in Renal Compromised State: How is the Combination?Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):374-375. doi: 10.4103/aian.aian_612_23. Epub 2023 Sep 11. Ann Indian Acad Neurol. 2023. PMID: 37970297 Free PMC article. No abstract available.
-
Mortality after major bleeding in Asian atrial fibrillation patients receiving different direct oral anticoagulants: a nationwide, propensity score study.Sci Rep. 2024 Feb 27;14(1):4771. doi: 10.1038/s41598-024-55500-z. Sci Rep. 2024. PMID: 38413742 Free PMC article.
References
-
- Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al.. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2):489–95. Epub 2004/12/14. doi: 10.1681/ASN.2004030203 . - DOI - PubMed
-
- Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al.. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15(5):1307–15. Epub 2004/04/22. doi: 10.1097/01.asn.0000123691.46138.e2 . - DOI - PubMed
-
- McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, et al.. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis. 2008;51(4 Suppl 2):S38–45. doi: 10.1053/j.ajkd.2007.12.017 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous